Invention Grant
- Patent Title: Disubstituted phthalazine hedgehog pathway antagonists
- Patent Title (中): 二取代的酞嗪酮刺猬通路拮抗剂
-
Application No.: US13590481Application Date: 2012-08-21
-
Publication No.: US09000023B2Publication Date: 2015-04-07
- Inventor: Philip Arthur Hipskind , Bharvin Kumar Patel , Takako Wilson (nee Takakuwa)
- Applicant: Philip Arthur Hipskind , Bharvin Kumar Patel , Takako Wilson (nee Takakuwa)
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Danica Hostettler
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/12 ; C07D401/14
Abstract:
The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.
Public/Granted literature
- US20120316174A1 DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS Public/Granted day:2012-12-13
Information query
